Sugar-modified derivatives of cytostatic 7-(het)aryl-7-deazaadenosines: 2'-C-methylribonucleosides, 2'-deoxy-2'-fluoroarabinonucleosides, arabinonucleosides and 2'-deoxyribonucleosides.

[1]  M. Rowley,et al.  Synthesis and antiviral properties of novel 7-heterocyclic substituted 7-deaza-adenine nucleoside inhibitors of Hepatitis C NS5B polymerase. , 2012, Bioorganic & medicinal chemistry.

[2]  I. Pichová,et al.  Synthesis and significant cytostatic activity of 7-hetaryl-7-deazaadenosines. , 2011, Journal of medicinal chemistry.

[3]  R. Pohl,et al.  Sugar-Modified Derivatives of Cytostatic 6-(Het)aryl-7-deazapurine Nucleosides: 2′-C-Methylribonucleosides, Arabinonucleosides and 2′-Deoxy-2′-fluoroarabinonucleosides. , 2011 .

[4]  R. Pohl,et al.  Phosphoramidate pronucleotides of cytostatic 6-aryl-7-deazapurine ribonucleosides. , 2011, Bioorganic & medicinal chemistry.

[5]  C. Cameron,et al.  Synthesis of a 6-methyl-7-deaza analogue of adenosine that potently inhibits replication of polio and dengue viruses. , 2010, Journal of medicinal chemistry.

[6]  Helena Zábranská,et al.  CycloSal‐phosphate Pronucleotides of Cytostatic 6‐(Het)aryl‐7‐deazapurine Ribonucleosides: Synthesis, Cytostatic Activity, and Inhibition of Adenosine Kinases , 2010, ChemMedChem.

[7]  R. Pohl,et al.  6-(Het)aryl-7-deazapurine ribonucleosides as novel potent cytostatic agents. , 2010, Journal of medicinal chemistry.

[8]  C. K. Chu,et al.  Structure-activity relationships of 7-deaza-6-benzylthioinosine analogues as ligands of Toxoplasma gondii adenosine kinase. , 2008, Journal of medicinal chemistry.

[9]  C. Galmarini,et al.  Cytotoxic nucleoside analogues: different strategies to improve their clinical efficacy. , 2008, Current medicinal chemistry.

[10]  F. Seela,et al.  7-Functionalized 7-deazapurine β-d and β-l-ribonucleosides related to tubercidin and 7-deazainosine: glycosylation of pyrrolo[2,3-d]pyrimidines with 1-O-acetyl-2,3,5-tri-O-benzoyl-β-d or β-l-ribofuranose , 2007 .

[11]  Kanyawim Kirtikara,et al.  Sulforhodamine B colorimetric assay for cytotoxicity screening , 2006, Nature Protocols.

[12]  P. Čapek,et al.  Cross-coupling reactions of unprotected halopurine bases, nucleosides, nucleotides and nucleoside triphosphates with 4-boronophenylalanine in water. Synthesis of (purin-8-yl)- and (purin-6-yl)phenylalanines. , 2006, Organic & biomolecular chemistry.

[13]  M. Otto,et al.  Cytostatic 6-arylpurine nucleosides. 6. SAR in anti-HCV and cytostatic activity of extended series of 6-hetarylpurine ribonucleosides. , 2005, Journal of medicinal chemistry.

[14]  Giovanni Migliaccio,et al.  A 7-Deaza-Adenosine Analog Is a Potent and Selective Inhibitor of Hepatitis C Virus Replication with Excellent Pharmacokinetic Properties , 2004, Antimicrobial Agents and Chemotherapy.

[15]  P. D. Cook,et al.  Structure-activity relationship of heterobase-modified 2'-C-methyl ribonucleosides as inhibitors of hepatitis C virus RNA replication. , 2004, Journal of medicinal chemistry.

[16]  Yoshinori Yamamoto,et al.  Copper‐Catalyzed Synthesis of N‐Unsubstituted 1,2,3‐Triazoles from Nonactivated Terminal Alkynes , 2004 .

[17]  W. Waud,et al.  Purine nucleoside antimetabolites in development for the treatment of cancer. , 2004, Current opinion in investigational drugs.

[18]  Quanlai Song,et al.  Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymerase. , 2004, Journal of medicinal chemistry.

[19]  A. M. Riley,et al.  Synthesis and Ca2+-mobilizing activity of purine-modified mimics of adenophostin A: a model for the adenophostin-Ins(1,4,5)P3 receptor interaction. , 2003, Journal of medicinal chemistry.

[20]  M. Erion,et al.  Adenosine kinase inhibitors. 3. Synthesis, SAR, and antiinflammatory activity of a series of l-lyxofuranosyl nucleosides. , 2003, Journal of medicinal chemistry.

[21]  P. Gannett,et al.  Efficient one-step Suzuki arylation of unprotected halonucleosides, using water-soluble palladium catalysts. , 2003, The Journal of organic chemistry.

[22]  M. Otto,et al.  Ribonucleoside Analogue That Blocks Replication of Bovine Viral Diarrhea and Hepatitis C Viruses in Culture , 2003, Antimicrobial Agents and Chemotherapy.

[23]  J. Mackey,et al.  Nucleoside analogues and nucleobases in cancer treatment. , 2002, The Lancet. Oncology.

[24]  S. Johnson,et al.  Nucleoside analogues in the treatment of haematological malignancies , 2001, Expert opinion on pharmacotherapy.

[25]  Michal Hocek,et al.  Cytostatic 6-Arylpurine Nucleosides III. Synthesis and Structure-Activity Relationship Study in Cytostatic Activity of 6-Aryl-, 6-Hetaryl- and 6-Benzylpurine Ribonucleosides , 2001 .

[26]  S. Johnson,et al.  Therapeutic potential of purine analogue combinations in the treatment of lymphoid malignancies , 2000 .

[27]  M. Erion,et al.  Adenosine kinase inhibitors. 1. Synthesis, enzyme inhibition, and antiseizure activity of 5-iodotubercidin analogues. , 2000, Journal of medicinal chemistry.

[28]  Michal Hocek,et al.  Synthesis and cytostatic activity of substituted 6-phenylpurine bases and nucleosides: application of the Suzuki-Miyaura cross-coupling reactions of 6-chloropurine derivatives with phenylboronic acids. , 2000, Journal of medicinal chemistry.

[29]  C. Martini,et al.  2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies. , 1998, Journal of medicinal chemistry.

[30]  F. Seela,et al.  The DNA-stabilising nucleoside 7-iodo-2′-deoxytubercidin: its structure in the solid state and in solution , 1996 .

[31]  K. Nebel,et al.  A novel synthesis of sulfamoyl nucleosides , 1994 .

[32]  D. Scudiero,et al.  Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. , 1988, Cancer research.

[33]  F. Seela,et al.  Liquid–liquid and solid–liquid phase-transfer glycosylation of pyrrolo[2,3-d]pyrimidines: stereospecific synthesis of 2-deoxy-β-D-ribofuranosides related to 2′-deoxy-7-carbaguanosine , 1988 .

[34]  R. K. Robins,et al.  A facile synthesis of tubercidin and related 7-deazapurine nucleosides via the stereospecific sodium salt glycosylation procedure , 1987 .

[35]  H. G. Howell,et al.  Fluorocarbohydrates in synthesis. An efficient synthesis of 1-(2-deoxy-2-fluoro-.beta.-D-arabinofuranosyl)-5-iodouracil (.beta.-FIAU) and 1-(2-deoxy-2-fluoro-.beta.-D-arabinofuranosyl)thymine (.beta.-FMAU) , 1985 .

[36]  E. De Clercq,et al.  Antiviral activity of C-5 substituted tubercidin analogues. , 1984, Journal of medicinal chemistry.

[37]  A. Cook,et al.  Synthesis of the Natural Product 5'-Deoxy-5-iodotubercidin and Related Halogenated Analogs , 1984 .

[38]  R. K. Robins,et al.  Pyrrolopyrimidine nucleosides. 3. The total synthesis of toyocamycin, sangivamycin, tubercidin, and related derivatives. , 1969, Journal of the American Chemical Society.

[39]  E. Reich,et al.  BIOLOGICAL AND BIOCHEMICAL PROPERTIES OF THE ANALOGUE ANTIBIOTIC TUBERCIDIN. , 1964, Proceedings of the National Academy of Sciences of the United States of America.

[40]  S. Suzuki,et al.  A new antibiotic, tubercidin. , 1957, The Journal of antibiotics.